Literature DB >> 22210997

Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway.

Kristin P Anfinsen1, Tom Grotmol, Oyvind S Bruland, Thora J Jonasdottir.   

Abstract

This is one of few published population-based studies describing breed specific rates of canine primary bone tumors. Incidence rates related to dog breeds could help clarify the impact of etiological factors such as birth weight, growth rate, and adult body weight/height on development of these tumors. The study population consisted of dogs within 4 large/giant breeds; Irish wolfhound (IW), Leonberger (LB), Newfoundland (NF), and Labrador retriever (LR), born between January 1st 1989 and December 31st 1998. Questionnaires distributed to owners of randomly selected dogs--fulfilling the criteria of breed, year of birth, and registration in the Norwegian Kennel Club--constituted the basis for this retrospective, population-based survey. Of the 3748 questionnaires received by owners, 1915 were completed, giving a response rate of 51%. Forty-three dogs had been diagnosed with primary bone tumors, based upon clinical examination and x-rays. The breeds IW and LB, with 126 and 72 cases per 10 000 dog years at risk (DYAR), respectively, had significantly higher incidence rates of primary bone tumors than NF and LR (P < 0.0001). Incidence rates for the latter were 11 and 2 cases per 10 000 DYAR, respectively. Pursuing a search for risk factors other than body size/weight is supported by the significantly different risks of developing primary bone tumors between similarly statured dogs, like NF and LB, observed in this study. Defining these breed-specific incidence rates enables subsequent case control studies, ultimately aiming to identify specific etiological factors for developing primary bone tumors.

Entities:  

Mesh:

Year:  2011        PMID: 22210997      PMCID: PMC3122972     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  33 in total

1.  Endogenous gonadal hormone exposure and bone sarcoma risk.

Authors:  Dawn M Cooley; Benjamin C Beranek; Deborah L Schlittler; Nita W Glickman; Lawrence T Glickman; David J Waters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-11       Impact factor: 4.254

2.  Survey of the Swedish dog population: age, gender, breed, location and enrollment in animal insurance.

Authors:  A Egenvall; A Hedhammar; B N Bonnett; P Olson
Journal:  Acta Vet Scand       Date:  1999       Impact factor: 1.695

Review 3.  Translation of new cancer treatments from pet dogs to humans.

Authors:  Melissa Paoloni; Chand Khanna
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

Review 4.  Comparative oncology today.

Authors:  Melissa C Paoloni; Chand Khanna
Journal:  Vet Clin North Am Small Anim Pract       Date:  2007-11       Impact factor: 2.093

5.  Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival.

Authors:  Agneta Egenvall; Ane Nødtvedt; Henrik von Euler
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

Review 6.  Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers.

Authors:  Chand Khanna; David M Vail
Journal:  Curr Cancer Drug Targets       Date:  2003-08       Impact factor: 3.428

7.  High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions.

Authors:  Gaetano Bacci; Michele Rocca; Mariacristina Salone; Alba Balladelli; Stefano Ferrari; Emanuela Palmerini; Cristiana Forni; Antonio Briccoli
Journal:  J Surg Oncol       Date:  2008-11-01       Impact factor: 3.454

8.  Results of a web-based health survey of retired racing Greyhounds.

Authors:  Linda K Lord; Jill E Yaissle; Liliana Marin; C Guillermo Couto
Journal:  J Vet Intern Med       Date:  2007 Nov-Dec       Impact factor: 3.333

9.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

10.  Demographic data of a population of insured Swedish dogs measured in a questionnaire study.

Authors:  M Sallander; A Hedhammar; M Rundgren; J E Lindberg
Journal:  Acta Vet Scand       Date:  2001       Impact factor: 1.695

View more
  15 in total

Review 1.  Recent and current clinical trials in canine appendicular osteosarcoma.

Authors:  Andrew C Poon; Arata Matsuyama; Anthony J Mutsaers
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

2.  Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.

Authors:  David A Largaespada; Jaime F Modiano; Subbaya Subramanian; Milcah C Scott; Nuri A Temiz; Anne E Sarver; Rebecca S LaRue; Susan K Rathe; Jyotika Varshney; Natalie K Wolf; Branden S Moriarity; Timothy D O'Brien; Logan G Spector; Aaron L Sarver
Journal:  Cancer Res       Date:  2017-10-24       Impact factor: 12.701

3.  Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.

Authors:  Kelly M Makielski; Alicia J Donnelly; Ali Khammanivong; Milcah C Scott; Andrea R Ortiz; Dana C Galvan; Hirotaka Tomiyasu; Clarissa Amaya; Kristin A Ward; Alexa Montoya; John R Garbe; Lauren J Mills; Gary R Cutter; Joelle M Fenger; William C Kisseberth; Timothy D O'Brien; Brenda J Weigel; Logan G Spector; Brad A Bryan; Subbaya Subramanian; Jaime F Modiano
Journal:  Lab Invest       Date:  2021-09-06       Impact factor: 5.662

4.  Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma.

Authors:  Sunetra Das; Rupa Idate; Daniel P Regan; Jared S Fowles; Susan E Lana; Douglas H Thamm; Daniel L Gustafson; Dawn L Duval
Journal:  Commun Biol       Date:  2021-10-11

5.  Estimated incidence rate and distribution of tumours in 4,653 cases of archival submissions derived from the Dutch golden retriever population.

Authors:  Kim M Boerkamp; Erik Teske; Lonneke R Boon; Guy C M Grinwis; Lindsay van den Bossche; Gerard R Rutteman
Journal:  BMC Vet Res       Date:  2014-01-31       Impact factor: 2.741

6.  Estimating canine cancer incidence: findings from a population-based tumour registry in northwestern Italy.

Authors:  Elisa Baioni; Eugenio Scanziani; Maria Claudia Vincenti; Mauro Leschiera; Elena Bozzetta; Marzia Pezzolato; Rosanna Desiato; Silvia Bertolini; Cristiana Maurella; Giuseppe Ru
Journal:  BMC Vet Res       Date:  2017-06-28       Impact factor: 2.741

Review 7.  Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.

Authors:  Siobhan Simpson; Mark David Dunning; Simone de Brot; Llorenç Grau-Roma; Nigel Patrick Mongan; Catrin Sian Rutland
Journal:  Acta Vet Scand       Date:  2017-10-24       Impact factor: 1.695

Review 8.  Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review.

Authors:  Kelly M Makielski; Lauren J Mills; Aaron L Sarver; Michael S Henson; Logan G Spector; Shruthi Naik; Jaime F Modiano
Journal:  Vet Sci       Date:  2019-05-25

9.  Occurrence of cardiorespiratory diseases and impact on lifespan in Swedish Irish Wolfhounds: a retrospective questionnaire-based study.

Authors:  Lovisa Orleifson; Ingrid Ljungvall; Katja Höglund; Jens Häggström
Journal:  Acta Vet Scand       Date:  2017-08-02       Impact factor: 1.695

Review 10.  Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.

Authors:  Jyotika Varshney; Milcah C Scott; David A Largaespada; Subbaya Subramanian
Journal:  Vet Sci       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.